Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Bay Area Life Sciences Professionals Weigh In on Their Ideal Employers
BioSpace
Tue, 10/29/19 - 10:23 am
San Francisco
Bay Area
Genentech
Gilead Sciences
Roche
Amgen
What to make of Gilead's latest NASH deal
Biopharma Dive
Mon, 10/28/19 - 11:04 pm
Gilead Sciences
Glympse Bio
biomarkers
NASH
State-Pharma Deals for Hepatitis C Drugs Come Under Scrutiny
BioSpace
Fri, 10/25/19 - 10:48 pm
hepatitis C
Washington state
AbbVie
Louisiana
Gilead Sciences
Asegua Therapeutics
Gilead’s filgotinib fails midphase tests in lupus, Sjogren's
Fierce Biotech
Fri, 10/25/19 - 10:39 am
Gilead Sciences
filgotinib
lupus
Sjögren’s syndrome
clinical trials
Gilead third-quarter results in line, but Yescarta sales dip
Yahoo/Reuters
Thu, 10/24/19 - 11:27 pm
Gilead Sciences
earnings
Yescarta
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Yahoo/Benzinga
Sun, 10/20/19 - 05:18 pm
earnings
Eli Lilly
Alexion
Gilead Sciences
Biomarin
Edwards Lifesciences
Baxter International
Integra LifeSciences
Phathom Pharmaceuticals
IPOs
Foamix
Eton Pharmaceuticals
Melinta Therapeutics
Ligand Pharmaceuticals
Will Strong HIV Sales Drive Gilead's (GILD) Q3 Earnings?
Yahoo/Zacks.com
Sat, 10/19/19 - 01:30 pm
Gilead Sciences
earnings
AbbVie, Gilead and Allergan 3-peat with September's top pharma TV spending
Fierce Pharma
Tue, 10/15/19 - 11:58 am
DTC ads
television ads
AbbVie
Humira
Gilead Sciences
Truvada
Allergan
Botox
Gilead, Galapagos share 52-week update on filgotinib
Fierce Biotech
Fri, 10/11/19 - 10:44 am
Gilead Sciences
Galapagos
filgotinib
clinical trials
rheumatoid arthritis
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
Tue, 10/8/19 - 10:53 am
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
Chasing AbbVie, Gilead files for approval of filgotinib in Japan
Fierce Biotech
Tue, 10/8/19 - 09:40 am
Gilead Sciences
JAK inhibitors
Japan
filgotinib
Galapagos
AbbVie
After more than a year, Gilead finds new chief medical officer
Biopharma Dive
Mon, 10/7/19 - 12:04 pm
Gilead Sciences
Roche
Genentech
Gilead scores PrEP approval for Descovy — kicking off marketing push before Truvada generics swarm
Endpoints
Thu, 10/3/19 - 10:21 pm
Gilead Sciences
Descovy
HIV
PrEP
FDA
Truvada
generics
3 Biotechs With the Biggest Cash Stockpiles
Motley Fool
Fri, 09/20/19 - 09:27 am
biotech
cash
Gilead Sciences
Amgen
Celgene
HIV-focused Gilead launches fund, pledges $2M to help transgender people
Fierce Pharma
Thu, 09/12/19 - 10:34 pm
Gilead Sciences
HIV
transgender
philanthropy
4 Key Questions for Gilead Sciences' New CEO
Motley Fool
Wed, 09/11/19 - 09:48 am
Gilead Sciences
Daniel O'Day
Pharma CEOs
FDA issues safety warning for newer hepatitis C drugs following patient deaths
Biopharma Dive
Wed, 08/28/19 - 11:02 pm
FDA
hepatitis C
FAERS
AbbVie
Mavyret
Merck
Zepatier
Gilead Sciences
Vosevi
Gilead, Galapagos finalise £4.1bn research and development deal
Pharmaceutical Business Review
Mon, 08/26/19 - 09:21 am
Gilead Sciences
Galapagos
R&D
AbbVie's Rinvoq label portends safety warnings for future JAKs—including Gilead's
Fierce Pharma
Tue, 08/20/19 - 09:45 am
JAK inhibitors
AbbVie
Rinvoq
FDA
Gilead Sciences
FDA AdCom backs Gilead's move to expand Descovy label — but stops short of endorsing broad PrEP use
Endpoints
Thu, 08/8/19 - 12:56 pm
FDA
Gilead Sciences
HIV
Descovy
PrEP
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »